Synthesis and Biological Evaluation of Esters of 16-Formyl-17-Methoxy-Dehydroepiandrosterone Derivatives as Inhibitors of 5α-Reductase Type 2

    Araceli Sánchez‐Márquez, Yazmín Arellano, Eugene Bratoeff … Marisa Cabeza
    Studysummary This study found that aliphatic ester moieties in 16-formyl-17-methoxy dehydroepiandrosterone derivatives increased their potency as 5α-reductase type 2 inhibitors in vitro compared to finasteride.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. New Ester Derivatives of Dehydroepiandrosterone as 5α-Reductase Inhibitors Steroids · 2011
    2. Molecular Interactions of Progesterone Derivatives with 5α-Reductase Types 1 and 2 and Androgen Receptors Steroids · 2010
    3. Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP-Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor Journal of the American Chemical Society · 1996

    Related research 3

    1. Synthesis and Biological Evaluation of Esters of 16-Formyl-17-Methoxy-Dehydroepiandrosterone Derivatives as Inhibitors of 5α-Reductase Type 2 Journal of Enzyme Inhibition and Medicinal Chemistry · 2015
    2. Role of 5α-Reductase Inhibitors in Benign Prostatic Diseases Prostate cancer and prostatic diseases · 2012
    3. Finasteride The New England Journal of Medicine · 1994